Literature DB >> 1594241

Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms.

M Fagioli1, M Alcalay, P P Pandolfi, L Venturini, A Mencarelli, A Simeone, D Acampora, F Grignani, P G Pelicci.   

Abstract

The acute promyelocytic leukaemia (APL)-specific chromosome 15;17 translocation leads to the fusion of a newly identified putative transcription factor, PML, and the retinoic acid receptor alpha. We have characterized the structure of the PML genomic locus and preliminarily characterized its expression pattern. The PML locus spans a minimum of 35 kb and is subdivided into nine exons. The putative PML DNA binding site is encoded by exons 2 and 3. We isolated a large number of alternatively spliced PML transcripts that encode numerous PML isoforms. Two groups of isoforms were identified that differed either in their C-terminal region or in the length of their central region, but retained the putative DNA-binding and dimerization domains. RNAase protection experiments revealed that the different PML isoforms are equally expressed in established cell lines of different histological origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594241

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.

Authors:  Johanna Congleton; Miaoqing Shen; Robert MacDonald; Fabio Malavasi; Andrew Yen
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

2.  Phosphorylation of the synthetic octapeptide pyroGlu-ASP-ASP-SER-ASP-GLU-GLU-ASN and binding to DNA in presence of divalent cations.

Authors:  E Cardellini; D Ponti; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1999-12       Impact factor: 2.316

3.  PML regulates PER2 nuclear localization and circadian function.

Authors:  Takao Miki; Zhixiang Xu; Misty Chen-Goodspeed; Mingguang Liu; Anita Van Oort-Jansen; Michael A Rea; Zhaoyang Zhao; Cheng Chi Lee; Kun-Sang Chang
Journal:  EMBO J       Date:  2012-01-24       Impact factor: 11.598

4.  Mass spectral and electrophoretic characterization of acidic peptides bound to chromatin of pea bud.

Authors:  L Mancinelli; G Lugaro; L De Angelis; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

5.  Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation.

Authors:  Jennifer K Dowling; Christine E Becker; Nollaig M Bourke; Sinead C Corr; Dympna J Connolly; Susan R Quinn; Paolo P Pandolfi; Ashley Mansell; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

6.  The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.

Authors:  M Alcalay; L Tomassoni; E Colombo; S Stoldt; F Grignani; M Fagioli; L Szekely; K Helin; P G Pelicci
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

7.  Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.

Authors:  Behdokht Jan Fada; Elie Kaadi; Subodh Kumar Samrat; Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

8.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

10.  Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.

Authors:  G W Carlile; W G Tatton; K L Borden
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.